No Detail Found!

In silico-prediction of chloroquine as a multi-targeted drug against CDKN2A signaling network associated with cutaneous malignant melanoma

Author(s)
Zainab Jan Department of Bioinformatics, Hazara University,Mansehra,Pakistan
Muhammad Aqeel National Institute for Genomics and Advance Biotechnology,NARC, Islamabad,Pakistan
Ammara Munir Department of Biotechnology, Virtual University, Pakistan;Department of Biotechnology, University of Azad Jammu and Kashmir, Pakistan
Aamir Saeed Department of Bioinformatics, Hazara University,Mansehra,Pakistan
Haleema Sadia Department of Biotechnology,BUITEMS, Quetta,Pakistan
Saeeda Kalsoom Department of Biotechnology, Virtual University,Pakistan
Tariq Nadeem Department of Biotechnology, Virtual University, Pakistan;National Center of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan
Zainab Bashir Department of Bioinformatics, Hazara University,Mansehra,Pakistan
Larayb Awan Department of Bioinformatics, Hazara University,Mansehra,Pakistan
Sami ud din Department of Genetic, Hazara University Mansehra,Pakistan
Ghulam Muhammad Ali National Institute for Genomics and Advance Biotechnology,NARC, Islamabad,Pakistan
Abstract
Melanoma is one of the most common skin infections, has triggered significant morbidity and mortality across the globe. Previous studies have reported that mutations in CDKN2A signalling network is associated with cutaneous malignant melanoma. In the present study, initially, the BioGrid database was utilized, and then hierarchical clustering was performed to identify the CDKN2A signature pathways. In addition, a GO Enrichment analysis was investigated using DAVID (n=187 genes) toolkit. Subsequently, the cBioPortal cancer genomic platform was exploited using alteration ranked frequency to determine the role of the CDKN2A signaling network in 363 samples of cutaneous malignant melanoma patients and we find that CDKN2A and its close interactors PTEN and HUWE1 show highest mutations. Further, we systematically employed molecular docking approach via MOE to target PTEN, CDKN2A and HUWE1 with chloroquine which is naturally occurring in medicinal plant Nigella sativa (NS) and observed virtuous interactions between all receptors and ligand molecules with a binding energy of -11.379, -10.324 and -9.06 Kcal/mol, respectively. The outcomes obtained stipulate a vigorous research resource for using chloroquine as a multitargeted anticancer drug. This novel evidence should help the development of effective therapeutic compounds for the treatment of cancer. Our results reveal that chloroquine is a relevant and novel potential therapeutic drug for the treatment of melanoma.
Publication Details
Page(s) 731-739
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 35, Issue: 3, Year: 2022

Request the full text from PASTIC

Keywords
molecular docking, Chloroquine, Cancer, signaling network, melanoma
0

Citations

0

Downloads

72

Views